New hope for tough lymphoma: experimental drug IPH6501 tested in early trial
Disease control
Terminated
This study tested an experimental drug called IPH6501 in 23 people with a type of blood cancer called Non-Hodgkin lymphoma that had returned or stopped responding to other treatments. The main goals were to check the drug's safety and find the best dose. The trial was stopped ear…
Phase: PHASE1, PHASE2 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC